期刊文献+

顶空气相色谱法测定熊去氧胆酸中3种有机溶剂残留量 被引量:2

Determination of Three Residual Solvents in Ursodeoxycholic Acid by Headspace Gas Chromatography
原文传递
导出
摘要 目的:建立顶空气相色谱法同时测定熊去氧胆酸原料药中3种有机溶剂残留量的方法。方法:用0.25 mol·L^-1的氢氧化钠溶液溶解样品,采用顶空进样-气相色谱法,应用FID检测器,在DB-WAX毛细管色谱柱(30.0 m×320μm×1.0μm)上程序升温(起始温度70℃,保持5分钟,再以15℃·min^-1的升温速率升至180℃,保持5分钟),载气为氮气,进样口温度200℃,检测器温度230℃。结果:待测组分均能得到有效分离,各组分在所考察的浓度范围内线性关系良好,r=0.9976-0.9996,平均回收率为91.00%-99.09%。结论:本方法可准确测定熊去氧胆酸原料药中丙酮、乙醇及N,N-二甲基甲酰胺的残留量,操作简便、准确度和灵敏度高,可达到有效控制其质量的目的。 Objective: To establish a headspace gas chromatography method for the determination of three residual solvents in ursodeoxycholic acid. Methods: Samples were resolved by 0.25 mol·L^-1Na OH, and then the concentration of residual solvents were measured by headspace gas chromatography using FID detector and DB-Wax capillary column(30.0 m×320 μm×0.5 μm) with temperature program(the initial temperature was kept at 70 ℃ for 5 min, then the temperature was raised to 180 ℃ at the rate of 15 ℃·min^-1and kept for 5 min). The inlet temperature was controlled at 200 ℃, and the detector temperature was 230 ℃, with nitrogen as the carrier gas.Results: The linear range(r=0.9976-0.9996) were satisfactory and three residual solvents were completely separated. The average recovery rates were 91.00%-99.09%. Conclusion: This method is simple, accurate and sensitive for detection of three residual solvents(acetone, ethyl alcohol and N, N-dimethylformamide) in ursodeoxycholic acid, and can be used for quality control.
出处 《现代生物医学进展》 CAS 2015年第31期6156-6159,共4页 Progress in Modern Biomedicine
基金 陕西省自然科学基金青年基金项目(2011JQ4017)
关键词 熊去氧胆酸 顶空气相色谱 溶剂残留 Ursodeoxycholic acid Headspace gas chromatography Residual organic solvent
  • 相关文献

参考文献20

  • 1佟爱东,劳瑞珍,李思源.薄层色谱法检查熊去氧胆酸的有关物质[J].药物分析杂志,2012,32(9):1654-1657. 被引量:6
  • 2Buko VU,Lukivskaya OY,Naruta BE,et al.Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioace- tamide-induced Rat Liver Fibrosis[J].J Clin Exp Hepatol,2014,4(4):293-301.
  • 3Kim JK,Lee KS,Lee DK,et al.Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet- induced nonalcoholic steatohepatitis in mice[J].Exp Mol Med,2014,46(12):el27.
  • 4Guo T,Chang L,Xiao Y,et al.S-adenosyl-L-methionine for the treat- ment of chronic liver disease:a systematic review and meta-analysis[J].PLoS One,2015,10(3):e0122124.
  • 5Sun B,Hartl F,Castiglione K,et al.Dynamic mechanistic modeling of the multienzymatic one-pot reduction of dehydrocholic acid to 12-keto ursodeoxycholic acid with competing substrates and cofactors[J].Biotechnol Prog,2015,31(2):375-386.
  • 6Brossard D,Lechevrel M,El Kihel L,et al.Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines[J].Eur J Med Chem,2014,86(1):279*290.
  • 7Eggert T,Bakonyi D,Hummel W.Enzymatic routes for the synthesis of ursodeoxycholic acid[J].J Biotechnol,2014,191(1):11-21.
  • 8张飞,赵静国,赵蒙浩.鹅去氧胆酸与熊去氧胆酸的合成工艺研究[J].化学与生物工程,2014,31(1):47-50. 被引量:12
  • 9国家食品药品监督管理局.化学药物残留溶剂研究的技术指导原则[S]. 2005.
  • 10周海均.药品注册的国际技术要求[M].人民卫生出版社,2000.

二级参考文献23

  • 1潘现军,张晓梅.从猪胆膏中分离纯化鹅去氧胆酸的新工艺[J].河北医药,2006,28(2):147-148. 被引量:10
  • 2胡先明,白丽霞,王丽燕,郭晓燕,李祥生,梁渊,卢祖洵.亚健康与心脑血管疾病[J].中西医结合心脑血管病杂志,2007,5(1):65-66. 被引量:9
  • 3唐玉红.HPLC法测定熊去氧胆酸含量[J].现代仪器,2007,13(1):62-62. 被引量:3
  • 4张国平 余晓岗 等.NBS氧化制备熊去氧胆酸中间体7-氧代石胆酸[J].中国医药工业杂志,1996,27(5):234-234.
  • 5ChP(中国药典).2010.VolⅡ(二部):922.
  • 6国家药典委员会.中国药典2010年版[s].二部.北京:中国医药科技出版社,2010:90.
  • 7The Merck Index. 14th ed. 2006. 1699.
  • 8BP. 2008. Vol Ⅱ :2231.
  • 9JP15.2006.357.
  • 10SHENG Long-sheng(盛龙生),He Li-yi(何丽一),XU Lian-linan(徐连连),et al,Pharmaceutical Analysis(药物分析).Bei jing(北京):Chemical Industry Press(化学工业出版社),2003.95.

共引文献18

同被引文献26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部